CAS RN: 121916-94-7

3A-Amino-3A-deoxy-(2AS,3AS)-α-cyclodextrin

Product Availability

Choose a grade to view its available package options.

4 package records3 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250502 200mg In stock Inquiry
Batchno.20250504 50mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250328 200mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260614 100mg Out of stock Inquiry
  • Product code: ICTA2122
  • Purity/Analytical Methods: >90.0%(HPLC)
GET A QUOTE

121916-94-7 / (5R,10R,15R,20R,25R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41S,42S)-41-amino-5,10,15,20,25,30-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane-31,32,33,34,35,36,37,38,39,40,42-undecol

Standard CAS: 121916-94-7 Multi CAS: No

Basic Information

CAS
121916-94-7
Multi CAS
No
Molecular Formula
C36H61NO29
Molecular Weight
971.900000
Exact Mass
971.332925
SMILES
C([C@@H]1C2[C@H]([C@@H](C(O1)OC3[C@H](OC([C@@H]([C@H]3O)O)OC4[C@H](OC([C@@H]([C@H]4O)O)OC5[C@H](OC([C@@H]([C@H]5O)O)OC6[C@H](OC([C@@H]([C@H]6O)O)OC7[C@H](OC(O2)[C@@H]([C@H]7O)O)CO)CO)CO)CO)CO)O)N)O
InChI
InChI=1S/C36H61NO29/c37-13-14(44)31-55-7(1-38)25(13)61-32-20(50)15(45)27(9(3-40)56-32)63-34-22(52)17(47)29(11(5-42)58-34)65-36-24(54)19(49)30(12(6-43)60-36)66-35-23(53)18(48)28(10(4-41)59-35)64-33-21(51)16(46)26(62-31)8(2-39)57-33/h7-36,38-54H,1-6,37H2/t7-,8-,9-,10-,11-,12-,13+,14+,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25?,26?,27?,28?,29?,30?,31?,32?,33?,34?,35?,36?/m1/s1
InChIKey
TXBHONGFOHSVMN-LRGPBYCASA-N

Computed Properties

Structural Parameters

Heavy atom count
66
Fraction Csp3
1
Rotatable bonds
6
H-bond acceptors
30
H-bond donors
18
Molar refractivity
197.77
TPSA
480.69

LogP / Solubility

WLOGP
-13.09
MLOGP
-11.43
XLogP3
-13.1
Consensus LogP
-12.54
Log S (ESOL)
2.78
Class (ESOL)
Highly soluble
Log S (Ali)
1.92
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
4.17
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-17.94

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us